INDIANAPOLIS, October 5, 2021 / PRNewswire / – Pulmodyne, Inc., a leading provider of drug spray delivery, and Alcove Manufacturing and Distribution, Inc., today announced the partnership between the two companies to expand distribution, integrate manufacturing and pursuing the joint development of new atomization technologies.
Pulmodyne, Inc and Alcove Manufacturing and Distribution announce partnership to innovate in atomization drug distribution
With this new partnership, Pulmodyne will begin to distribute the EZ-Spray atomization system through its existing channels. In addition to distribution, the partnership seeks to further innovate in the space, and this relationship will allow the two experienced companies to quickly optimize product design.
The global mucosal atomization market is growing rapidly, with significant increases expected due to flourishing trends such as non-invasive trends and needleless drug delivery systems. From rapid intranasal drug delivery to local anesthetics, the technology’s broad applications offer significant benefits for both the patient and the clinician. The integration between Pulmodyne and Alcove provides a broad portfolio of gas and syringe delivery systems.
“The EZ-Spray System has been a benchmark in drug atomization for years. I am pleased to announce that we are not only adding it to our existing atomization portfolio, but partnering with a company extremely experienced in developing the next generation of devices, ”said Pulmodyne President, Andrew Shurig.
Pulmodyne will manufacture and distribute the EZ-Spray device from the fourth quarter of 2021. Additional atomization offerings are expected in late 2022.
For more information about the company and the markets it serves, visit www.pulmodyne.com.
View original content to download multimedia: https://www.prnewswire.com/news-releases/pulmodyne-inc-and-alcove-manufacturing-and-distribution-announce-partnership-to-continue-innovation-in-drug -atomization -delivery-301392826.html